Iskra Michael S.
Known title: EVP & CCOCIK: 0001839432
Associated companies
Transaction History
| QDEL | ▲ Buy | Grant | 3,594 | $0 | 6/1/2024 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 1,300 | $57K | 6/1/2024 | View on chart |
| QDEL | ▲ Buy | Grant | 4,925 | $0 | 3/28/2024 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 1,773 | $85K | 3/28/2024 | View on chart |
| QDEL | ▲ Buy | Grant | 3,594 | $0 | 6/1/2023 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 1,839 | $158K | 6/1/2023 | View on chart |
| QDEL | ▲ Buy | Grant | 15,825 | $0 | 4/1/2023 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 6,930 | $617K | 4/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
QuidelOrtho Reports Q2 2026 Results and New IR Lead
QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.
QuidelOrtho Reports Q2 2026 Results and New IR Lead. QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.